Prognostic Value of Tumor Markers in Small Cell Lung Cancer
Author Information
Author(s): A. van der Gaast, W.L.J. van Putten, R. Oosterom, M. Cozijnsen, R. Hoekstra, T.A.W. Splinter
Primary Institution: University Hospital Rotterdam-Dijkzigt
Hypothesis
The study aims to determine the prognostic value of serum tumor markers for response and survival in patients with small cell lung cancer.
Conclusion
Thymidine kinase, tissue polypeptide antigen, and lactate dehydrogenase are valuable prognostic factors for survival in small cell lung cancer, while neuron specific enolase is not.
Supporting Evidence
- Thymidine kinase, tissue polypeptide antigen, and lactate dehydrogenase correlated significantly with survival.
- Neuron specific enolase did not correlate with survival.
- All markers were interrelated and correlated with the extent of disease.
Takeaway
Doctors looked at certain blood markers to see if they could predict how long patients with lung cancer would live. They found that some markers were helpful, but one marker wasn't.
Methodology
The study involved 70 untreated patients with small cell lung cancer, measuring serum levels of various tumor markers and correlating them with survival and disease extent.
Limitations
The sample size was limited, which may affect the generalizability of the findings.
Participant Demographics
Median age was 63 years, with 77% male and 13% female participants.
Statistical Information
P-Value
0.001 for TK, 0.003 for TPA, 0.008 for LDH
Confidence Interval
0.41-0.72 for TK, 0.33-0.70 for TPA, 0.23-0.61 for NSE, 0.26-0.65 for LDH
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website